Bob Steele, SCPN Co-director, Professor of Surgery at the University of Dundee and chair of the UK National Screening Committee
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the four UK countries about all aspects of screening and supports implementation of screening programmes. In 2016, Prof Bob Steele (Director of Centre for Research into Cancer Prevention and Screening, University of Dundee) was appointed independent chair of this committee. We asked him a few questions about topical issues in cancer screening.
The UK NSC reviewed the evidence for screening men for prostate cancer last year at its November meeting. Whilst it found that the evidence suggests that prostate screening does reduce prostate cancer deaths, the Committee’s overall recommendation was that population screening for prostate cancer should not be offered at this time.
This is because:
The Committee continues to monitor the findings from large trials (the PROTECT study most recently) to see if improvements in tests and treatments will shift the balance of harms and benefit of PSA testing in favour of screening.
In the meantime, the National Institute for Health and Care Excellence (NICE) guidelines for Suspected cancer: recognition and referral (June 2015) is available to help GPs assess when it is appropriate to refer patients for suspected cancer, including prostate cancer. The guidelines are available on NICE’s website at www.nice.org.uk/guidance/ng12.
Yes, a combination of the circulating tumour marker CA125 (a blood test) and an ultrasound does appear to detect ovarian cancer early. However, the UK Collaborative Trial of Ovarian Cancer Screening has yet to demonstrate that this will prevent deaths from ovarian cancer if it were used in a national screening programme. The UK NSC will wait for further data before a review of the recommendation can be made.
Yes, this is a concern, and it is important that “quit rates” are analysed in the ongoing trials of lung cancer screening.
Costs in the NHS and in the private sector are not strictly comparable and charges for private procedures are highly variable, but a rough estimate would put the cost of a colonoscopy
at around £1800.
This issue has a brand new look and feel. We listened to feedback from our annual survey that indicated an appetite for more science in our newsletter (especially research taking place in Scotland), examples of good practice and more of a public health dimension. We have grouped these themes together and colour coded the science section orange for easy access.